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Resistance of the pathogenic bacteria to available antibiotics is
quickly becoming a major problem in the community and hos-
pital based healthcare settings. The search for novel agents to
combat resistant bacteria has become one of the most impor-
tant areas of antibacterial research today [1]. Since the last five
decades very rapid progress has been made in the area of can-
cer cell biology, though most cancer treatments are still multi-
modal, involving chemotherapy and radiotherapy with
chemotherapy remaining the most significant pharmacological
approximation to cancer treatment [2]. Cancer is the second
leading cause of death in the world after cardiovascular dis-
eases and it is projected to be the primary cause of death withinthe coming year [3,4]. Breast cancer may be one of the oldest
known forms of cancerous tumours in humans. Worldwide,
breast cancer is the most common cancer in women, after skin
cancer, representing 16% of all female cancers [5]. Heterocyclic
chemistry is of great importance to medicinal chemists because
the steady growth of interest in heterocyclic compounds is con-
nected with their therapeutic activity. Further, the compounds
containing the 2-thioxothiazolidin-4-one ring (rhodanine) scaf-
fold has been gaining prominence in recent years, due to the
fact that its derivatives are known to possess a wide spectrum
of pharmacological activities, such as antimicrobial [6–10],
antidiabetic [11], anticancer [12–14], antiviral [15,16], antifun-
gal [17], anticonvulsant [18], anti-tuberculosis [19,20] and
anti-HIV [21]. The identification of a novel structure that
can be potentially useful in designing new, potent selective
and less toxic anticancer agents is still a major challenge to
medicinal chemistry researchers [22]. It is recently reported
that substituted thiazolidinones inhibit the MurB enzyme, an
integral component in bacterial peptidoglycan biosynthesis,
at low micromolar level [23,24] and the synthesized structures
of rhodanine containing moiety are shown in (Fig. 1).
In view of the above considerations and in continuation of
our previous work on triazoles, pyrimidine, thiazoles andzol-2-yl)
Figure 1 Previously reported MurB enzyme inhibitor and synthesized compounds.
2 D.N. Pansare, D.B. Shindethiazolidinones of pharmaceutical interest [25,26], we report
here on the synthesis and characterization of a novel series
of (Z)-2-((4-oxo-5-(thiophen-2-ylmethylene)-4,5-dihydrothia
zol-2-yl)amino) substituted acid (6a-l).2. Experimental
2.1. Instruments
2-Thioxothiazolidin-4-one, thiophene-2-carbaldehyde, anhy-
drous sodium acetate, triethylamine, amino acids, dichloro-
methane, iodomethane and various solvents were
commercially available. The major chemicals were purchased
from Sigma Aldrich and Avra labs. The reaction courses were
monitored by TLC on silica gel precoated F254 Merck plates.
Developed plates were examined with UV lamps (254 nm). IR
spectra were recorded on a FT-IR (Bruker). Melting points
were recorded on SRS Optimelt, melting point apparatus
and are uncorrected. 1H NMR spectra were recorded on a
400 MHz Bruker spectrometer. Chemical shifts are reported
as dppm units. The following abbreviations are used; singlet
(s), doublet (d), triplet (t), quartet (q), multiplet (m) and broad
(br). Mass spectra were taken with Micromass-QUATTRO-II
of WATER mass spectrometer.
2.2. Synthesis
2.2.1. General procedure for the synthesis of compounds (3)
In a 100 ml round bottom flask, an equimolar amount of 2-
thioxothiazolidin-4-one (1 mmol), anhydrous sodium acetate
(1 mmol), glacial acetic acid (5 mL) and thiophene-2-
carbaldehyde were added to the reaction mixture. The mixture
was stirred under reflux condition for 3 h. The progress of the
reaction was monitored by TLC (20% ethyl acetate: n-hexane).
After completion of the reaction, the reaction mixture was
poured into ice-cold water. The precipitate was filtered,Please cite this article in press as: D.N. Pansare, D.B. Shinde, A facile synthesis o
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tallization in ethanol as solvent to give 95% yield.
2.2.1.1. (Z)-5-(thiophen-2-ylmethylene)-2-thioxothiazolidin-4-
one (3). Yellow solid. Yield: 95%. mp 231–233 C; ES–MS
m/z (%): 227.33. IR mmax/cm1: 3175 (NH), 1680 (C‚O),
1582 (‚C), 1438 (C‚N), 1225 (C‚S), 1052 (CAN). 1H
NMR (400 MHz, DMSO-d6): dppm = 7.40–7.55 (m, 3H,
ArACH), 7.55 (s, 1H, ‚CH), 7.70 (s, 1H, NH).
2.2.2. General procedure for the synthesis of compounds (4)
In a 100 ml round bottom flask, the compound (3) (1 mmol),
triethylamine (1.5 mmol) was added in dichloromethane
(5 mL) at room temperature. To the stirred reaction mixture
iodomethane (1.5 mmol) was added after 5 min and stirred
for 2 h at room temperature. The progress of the reaction
was monitored by TLC (10% chloroform: methanol). After
completion of the reaction the reaction mixture was concen-
trated in-vacuo. The residue was washed out with water
(3  15 mL) to afford the crude product. The crude product
was recrystallized using ethanol as solvent to give yields in
the range of 94%.
2.2.2.1. (Z)-2-(methylthio)-5-(thiophen-2-ylmethylene)thiazol-
4(5H)-one (4). Yellow solid. Yield: 94%. mp 150–152 C; ES–
MS m/z (%): 241.35. IR mmax/cm1: 1672 (C‚O), 1581
(C‚C), 1461 (C‚N), 1220 (CAS), 1003 (CAN). 1H NMR
(400 MHz, DMSO-d6): dppm = 2.85 (s, 3H, SACH3), 7.50–
7.75 (m, 3H, ArACH), 7.95 (s, 1H, ‚CH).
2.2.3. General procedure for the synthesis of (Z)-2-((4-oxo-5-
(thiophen-2-ylmethylene)-4,5-dihydrothiazol-2-yl)amino)
substituted acid (6a-l)
In a 100 ml round bottom flask, the compound (4) (1 mmol),
ethanol (5 mL), and amino acids (5a-l) (1.5 mmol) were added
in water (5 mL). To the stirred reaction mixture a catalytic
amount of potassium carbonate (1.5 mmol) was added andf novel series (Z)-2-((4-oxo-5-(thiophen-2-ylmethylene)-4,5-dihydrothiazol-2-yl)
g/10.1016/j.jscs.2015.10.005
Synthesis of novel series of substituted acid 3stirred for 16–20 min at room temperature. The progress of the
reaction was monitored by TLC (10% chloroform: methanol).
After completion of the reaction the reaction mixture was con-
centrated in-vacuo. The residue was washed with water
(3  15 mL) to afford the crude product. The compounds
(6a-l) were recrystallized from ethyl alcohol and isolated as yel-
lowish powders.
2.2.3.1. (Z)-2-((4-oxo-5-(thiophen-2-ylmethylene)-4,5-dihy-
drothiazol-2-yl)amino)propanoic acid (6a). Yellow solid.
Yield: 98%, mp 210–212 C; ES–MS m/z (%): 282.34. IR
mmax/cm1: 3397 (OH), 2850 (CHAAr), 1734 (HOAC‚O),
1649 (C‚O), 1607 (C‚C), 1486 (C‚N), 1217 (CAS), 1088
(CAN). 1H NMR (400 MHz, DMSO-d6): dppm = 1.40–1.45
(d, 3H, CACH3), 4.55–4.65 (q, 1H, CH), 7.25 (s, 1H, ‚CH),
7.55–7.95 (m, 3H, ArACH), 9.90 (s, 1H, NH), 13.01 (s, 1H,
COOH).
2.2.3.2. (Z)-3-methyl-2-((4-oxo-5-(thiophen-2-ylmethylene)-
4,5-dihydrothiazol-2-yl)amino) butanoic acid (6b). Yellow
solid. Yield: 95%, mp 214–216 C; ES–MS m/z (%): 310.30.
IR mmax/cm1: 3563 (OH), 2969 (NH), 1730 (HOAC‚O),
1641 (C‚O), 1584 (C‚C), 1490 (C‚N), 1183 (CAS), 1093
(CAN). 1H NMR (400 MHz, DMSO-d6): dppm = 0.90–1.08
(d, 6H, CH(CH3)2), 2.20–2.35 (m, 1H, CH), 4.50–4.60 (d,
1H, CH), 7.25 (s, 1H, ‚CH), 7.55–7.90 (m, 3H, ArACH),
8.35 (s, 1H, NH), 9.90 (s, 1H, COOH).
2.2.3.3. (Z)-3-methyl-2-((4-oxo-5-(thiophen-2-ylmethylene)-
4,5-dihydrothiazol-2-yl)amino) pentanoic acid (6c). Yellow
solid. Yield: 96%, mp 190–192 C; ES–MS m/z (%): 324.42.
IR mmax/cm1: 3398 (OH), 3212 (NH), 3017 (CHAAr), 1735
(HOAC‚O), 1692 (C‚O), 1557 (C‚C), 1583 (C‚N), 1013
(CAS), 1097 (CAN). 1H NMR (400 MHz, DMSO-d6):
dppm = 0.90–0.98 (t, 3H, CH2ACH3), 1.20–1.26 (d, 3H, CH3)
1.55–1.70 (m, 2H, CH2), 1.81–1.93 (m, 1H, CH), 4.43–4.72
(d, 1H, CH), 7.20 (s, 1H, ‚CH), 7.60–7.90 (m, 3H, ArACH),
8.60 (s, 1H, NH), 13.10 (s, 1H, COOH).
2.2.3.4. (Z)-2-((4-oxo-5-(thiophen-2-ylmethylene)-4,5-dihy-
drothiazol-2-yl)amino)-3-phenyl propanoic acid (6d). Yellow
solid. Yield: 92%, mp 169–171 C; ES–MS m/z (%): 358.43.
IR mmax/cm1: 3396 (OH), 3211 (NH), 2992 (CH–Ar), 1737
(HOAC‚O), 1692 (C‚O), 1551 (C‚C), 1581 (C‚N), 1017
(CAS), 1098 (CAN). 1H NMR (400 MHz, DMSO-d6):
dppm = 2.50–2.62 (d, 2H, CH2), 4.43–4.68 (q, 1H, CH), 7.30–
7.40 (m, 5H, ArACH), 7.50 (s, 1H, ‚CH), 7.78–7.90 (m,
3H, ArACH), 9.60 (s, 1H, NH), 13.30 (s, 1H, COOH).
2.2.3.5. (Z)-4-(methylthio)-2-((4-oxo-5-(thiophen-2-ylmethy-
lene)-4,5-dihydrothiazol-2-yl)amino) butanoic acid (6e). Yel-
low solid. Yield: 95%, mp 135–137 C; ES–MS m/z (%):
342.46. IR mmax/cm1: 3398 (OH), 3200 (NH), 2981
(CHAAr), 1733 (HOAC‚O), 1697 (C‚O), 1541 (C‚C),
1586 (C‚N), 1014 (CAS), 1091 (CAN). 1H NMR
(400 MHz, DMSO-d6): dppm = 2.01–2.15 (q, 2H, CH2), 2.20
(s, 3H, CH3), 2.60–2.72 (t, 2H, CH2), 4.43–4.72 (q, 1H, CH),
7.48 (s, 1H, ‚CH), 7.60–7.80 (m, 3H, ArACH), 9.60 (s, 1H,
NH), 13.15 (s, 1H, COOH).
2.2.3.6. (Z)-4-methyl-2-((4-oxo-5-(thiophen-2-ylmethylene)-
4,5-dihydrothiazol-2-yl)amino) pentanoic acid (6f). YellowPlease cite this article in press as: D.N. Pansare, D.B. Shinde, A facile synthesis o
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IR mmax/cm1: 3397 (OH), 3212 (NH), 3013 (CHAAr), 1734
(HOAC‚O), 1691 (C‚O), 1555 (C‚C), 1583 (C‚N), 1013
(CAS), 1091 (CAN). 1H NMR (400 MHz, DMSO-d6):
dppm = 0.92–0.99 (d, 6H, CHA(CH3)2), 1.40–1.55 (m, 1H,
CH), 1.70–1.88 (t, 2H, CH2), 4.44–4.80 (q, 1H, CH), 7.50 (s,
1H, ‚CH), 7.80–7.98 (m, 3H, ArACH), 9.62 (s, 1H, NH),
13.60 (s, 1H, COOH).
2.2.3.7. (Z)-3-hydroxy-2-((4-oxo-5-(thiophen-2-ylmethylene)-
4,5-dihydrothiazol-2-yl)amino) propanoic acid (6g). Yellow
solid. Yield: 96%, mp 218–220 C; ES–MS m/z (%): 298.34.
IR mmax/cm1: 3450 (OH), 3211 (NH), 3008 (CHAAr), 1739
(HOAC‚O), 1689 (C‚O), 1551 (C‚C), 1511 (C‚N), 1019
(CAS), 1097 (CAN). 1H NMR (400 MHz, DMSO-d6):
dppm = 3.70 (s, 1H, OH), 4.02–4.19 (t, 1H, CH), 4.23–4.48
(d, 2H, CH2), 7.60 (s, 1H,‚CH), 7.80–7.98 (m, 3H, ArACH),
9.90 (s, 1H, NH), 13.35 (s, 1H, COOH).
2.2.3.8. (Z)-3-mercapto-2-((4-oxo-5-(thiophen-2-ylmethy-
lene)-4,5-dihydrothiazol-2-yl)amino) propanoic acid (6h). Yel-
low powder. Yield: 98%, mp 191–193 C; ES–MS m/z (%):
314.40. IR mmax/cm1: 3455 (OH), 3201 (NH), 3017
(CHAAr), 2500 (SH), 1738 (HOAC‚O), 1695 (C‚O), 1559
(C‚C), 1501 (‚N), 1011 (CAS), 1099 (CAN). 1H NMR
(400 MHz, DMSO-d6): dppm = 1.50 (s, 1H, SH), 3.11–3.24
(d, 2H, CH2), 4.13–4.37 (t, 1H, CH), 7.45 (s, 1H, ‚CH),
7.65–7.80 (m, 3H, ArACH), 9.61 (s, 1H, NH), 13.11 (s, 1H,
COOH).
2.2.3.9. (Z)-2-((4-oxo-5-(thiophen-2-ylmethylene)-4,5-dihy-
drothiazol-2-yl)amino)succinic acid (6i). Yellow solid. Yield:
98%, mp 240–242 C; ES–MS m/z (%): 326.35. IR mmax/
cm1: 3464 (OH), 3213 (NH), 3020 (CHAAr), 1732
(HOAC‚O), 1689 (C‚O), 1549 (C‚C), 1503 (C‚N), 1030
(CAS), 1089 (CAN). 1H NMR (400 MHz, DMSO-d6):
dppm = 2.60–2.68 (d, 2H, CH2), 3.71–3.88 (t, 1H, CH), 7.68
(s, 1H, ‚CH), 7.75–7.95 (m, 3H, ArACH), 9.60– (s, 1H,
NH), 13.129 (s, 2H, COOH).2.2.3.10. (Z)-3-(1H-imidazol-4-yl)-2-((4-oxo-5-(thiophen-2-
ylmethylene)-4,5-dihydrothiazol-2-yl)amino)propanoic acid
(6j). Yellow solid. Yield: 94%, mp 206–208 C; ES–MS m/z
(%): 348.40 (M+H). IR mmax/cm1: 3435 (OH), 3215 (NH),
3011 (CHAAr), 1739 (HOAC‚O), 1681 (C‚O), 1552
(C‚C), 1508 (C‚N), 1033 (CAS), 1092 (CAN). 1H NMR
(400 MHz, DMSO-d6): dppm = 2.92–3.19 (d, 2H, CH2), 3.73–
3.86 (t, 1H, CH), 7.40 (s, 1H, ‚CH), 7.70–7.85 (m, 3H, Ar–
CH), 7.90 (s, 1H, ‚CH), 8.10 (s, 1H, ‚CH), 9.62 (s, 1H,
NH), 13.00 (s, 1H, NH), 13.34 (s, 1H, COOH).2.2.3.11. (Z)-3-(4-hydroxyphenyl)-2-((4-oxo-5-(thiophen-2-
ylmethylene)-4,5-dihydrothiazol-2-yl)amino)propanoic acid
(6k). Yellow solid. Yield: 94%, mp 245–247 C; ES–MS m/z
(%): 374.43. IR mmax/cm1: 3466 (O‚CAOH), 3395 (OH),
3215 (NH), 2991 (CHAAr), 1738 (HOAC‚O), 1697 (C‚O),
1553 (C‚C), 1591 (‚N), 1011 (CAS), 1089 (CAN). 1H
NMR (400 MHz, DMSO-d6): dppm = 2.80–2.98 (d, 2H,
CH2), 4.43–4.72 (t, 1H, CH), 5.30 (s, 1H, OH), 7.10–7.30 (m,
4H, ArACH), 7.40 (s, 1H,‚CH), 7.70–7.82 (m, 3H, ArACH),
9.62 (s, 1H, NH), 13.32 (s, 1H, COOH).f novel series (Z)-2-((4-oxo-5-(thiophen-2-ylmethylene)-4,5-dihydrothiazol-2-yl)
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lene)-4,5-dihydrothiazol-2-yl)amino) butanoic acid (6l). Yel-
low solid. Yield: 98%, mp 205–207 C; ES–MS m/z (%):
312.36. IR mmax/cm1: 3462 (OH), 3203 (NH), 3011
(CHAAr), 1737 (HOAC‚O), 1683 (C‚O), 1554 (C‚C),
1596 (C‚N), 1042 (CAS), 1115 (CAN). 1H NMR
(400 MHz, DMSO-d6): dppm = 1.13–1.29 (d, 3H, CH3), 3.51–
3.58 (d, 1H, CH), 3.77 (s, 1H, OH), 3.80–3.90 (m, 1H, CH),
7.25 (s, 1H, ‚CH), 7.50–7.68 (m, 3H, ArACH), 9.60 (s, 1H,
NH), 13.40 (s, 1H, COOH).3. Results and discussion
Compound (3) was then subjected to a Knoevenagel condensa-
tion with the appropriate 2-thioxothiazolidin-4-one, which had
themselves been synthesized using the reported procedure
[27,28] to provide a new series of target compounds (6a-l).
The structures of the desired compounds were confirmed by
IR, 1H NMR and Mass spectral analysis. The compound
(Z)-5-(thiophen-2-ylmethylene)-2-thioxothiazolidin-4-one (3)
was prepared in prominent good yields via a Knoevenagel con-
densation between the corresponding heterocyclic cores of rho-
danine, and a range of thiophene-2-carbaldehyde (Scheme 1).
2-thioxothiazolidin-4-one based compounds were synthesized
by conventional heating with sodium acetate which acts as a
base and glacial acetic acid as catalyst. In theory the presence
of E and Z geometrical isomers around the exocyclic double
bond (CH‚C) is possible for (Z)-5-(thiophen-2-ylmethy
lene)-2-thioxothiazolidin-4-one (3). The IR spectrum of com-
pound (3), showed a strong absorption band at 1680 cm1 that
is due to a carbonyl group. The mass spectrum revealed a
molecular ion peak at m/z= 227.33 corresponding to a molec-
ular formula C8H5NOS3.
1H NMR spectra of compounds (3)
show only one signal for the methyne proton in the range d
7.55 ppm, at lower field values than those expected for the
E-isomers, which strongly indicates that the compounds have
the Z-configuration. The latter has been reported as thermody-
namically more stable than the E-configuration [29,30]. Com-
pound (4) was synthesized (Scheme 1) from compound (3)
and the structures of the desired compounds were confirmedCHO
S
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O
S
O
+
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S
Scheme 1 Synthesis of (Z)-2-(methylthio)-5-(th
Scheme 2 Screening of model reaction (Z)-2-((4-oxo-5-(thiophen-2-
Please cite this article in press as: D.N. Pansare, D.B. Shinde, A facile synthesis o
amino) substituted acid, Journal of Saudi Chemical Society (2015), http://dx.doi.orby IR, 1H NMR and mass spectral analysis. The IR spectrum
of (Z)-2-(methylthio)-5-(thiophen-2-ylmethylene)thiazol-4(5H)-
one (4), showed a strong absorption band at 1672 cm1 that
is due to a carbonyl group. The mass spectrum revealed a
molecular ion peak at m/z= 241.35 corresponding to a molec-
ular formula C9H7NOS3.
1H NMR spectra of compound (4)
show one singlet for the methyne proton in the range d
7.95 ppm, sulfur attached to the methyl proton shows the
singlet in the range of d 2.85 ppm.
We synthesized and screened (Z)-2-((4-oxo-5-(thiophen-
2-ylmethylene)-4,5-dihydrothiazol-2-yl)amino)propanoic acid
(6a) in a model reaction (Scheme 2, Table 1).
aReaction condition (6a). Compound (4) (1 mmol), Com-
pound (5a) (1.2 mmol), Base (1 mmol), solvent 1 mL, stirring
at rt 20–80 min. The reaction in which compound 4 (1 mmol)
and compound 5a (1.2 mmol), catalyzed by various bases and
various solvents were selected as a model reaction to optimize
the reaction conditions. In terms of the effect of solvents and
bases on the condensation reaction, potassium carbonate was
found to be the better base and ethanol was found to be the
best solvent for the reaction (Table 1, entry 11); other solvents,
including methanol, acetic acid, N,N-dimethylformamide
(DMF) and toluene were less efficient (Table 1, entries 2–5,
7–10 and 12–15). Nevertheless, all of these yields were gener-
ally low before further optimizations. Ethanol gave the corre-
sponding product in 80–98% yield, which was the best among
these solvents (Table 1, entries 1, 6 and 11). To increase the
efficiency of the condensation reaction, the effects of different
bases were investigated (Table 1, entries 1–15). Potassium car-
bonate exhibited the best performance with used solvents and
gave better yield, (Table 1, entries 11–15). Sodium acetate and
triethylamine gave lower yields with other solvents, but gave
better yield in combination with ethanol as a solvent (Table 1,
entries 1 and 6). All the reactions were carried out in equimolar
amounts of each compound in 1 mL of solvent. Among these
reactions same amounts of the solvent, namely 1 mL of etha-
nol turned out to be the best choice with yields of 82%, 80%
and 98% (Table 1, entries 1, 6 and 11). We would like to men-
tion here that ethanol as a solvent with potassium carbonate as
base was the best choice with a yield of 98% and less time was
required for the completion of the reaction (Table 1, entry 11).Et3N, MeI
DCM, rt
S
NH
S S
N
O
S
3 4
S
iophen-2-ylmethylene)thiazol-4(5H)-one (4).
ylmethylene)-4,5-dihydrothiazol-2-yl)amino)propanoic acid (6a)a.
f novel series (Z)-2-((4-oxo-5-(thiophen-2-ylmethylene)-4,5-dihydrothiazol-2-yl)
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Table 1 Screening of catalyst, solvents, reaction time, and
yield for the synthesis of 6a.a
Entry Base Solvent Time
(min)
Yieldb
(%)
1 Triethylamine Ethanol 50 82
2 Triethylamine Methanol 60 65
3 Triethylamine Acetic
acid
65 60
4 Triethylamine DMF 70 60
5 Triethylamine Toluene 80 50
6 Sodium acetate Ethanol 50 80
7 Sodium acetate Methanol 55 50
8 Sodium acetate Acetic
acid
65 55
9 Sodium acetate DMF 70 45
10 Sodium acetate Toluene 90 55
11 Potassium
carbonate
Ethanol 20 98
12 Potassium
carbonate
Methanol 50 70
13 Potassium
carbonate
Acetic
acid
55 65
14 Potassium
carbonate
DMF 70 60
15 Potassium
carbonate
Toluene 80 60
a The entire reaction was carried out in equimolar amounts of
each compound in 1 mL of solvent.
b Isolated yield.
Table 2 Synthesis of (Z)-2-((4-oxo-5-(thiophen-2-ylmethy-
lene)-4,5-dihydrothiazol-2-yl)amino) substituted acid (6a-l).a
Compounds Substituent
(R)
Time
(min)
Yieldb
(%)
Melting point
(C)
6a –CH3 20 98 210–212
6b –CH(CH3)2 16 95 214–216
6c –CH(CH3)
CH2CH3
20 96 190–192
6d –CH2C6H5 20 92 169–171
6e –
CH2CH2SCH3
20 95 135–137
6f –CH2CH
(CH3)2
16 96 180–182
6g –CH2OH 18 96 218–220
6h –CH2SH 18 98 191–193
6i –CH2COOH 16 98 240–242
6j 16 94 206–208
6k –CH2C6H4OH 16 94 245–247
6l –CHOHCH3 18 98 205–207
a Reaction condition (6a-l): Compound (4) (1 mmol), amino acids
(5a-l) (1.2 mmol), K2CO3 (1.2 mmol), 1 mL Ethanol, Room
temperature.
b Isolated yields.
Synthesis of novel series of substituted acid 5Thus we decided to carry out the further reactions in ethanol
with potassium carbonate. As a result the reaction time was
shortened; thermal decomposition was also minimized, at
room temperature with stirring, resulting in higher isolated
yields.
We synthesized the series of novel (Z)-2-((4-oxo-5-(thiophen-
2-ylmethylene)-4,5-dihydrothiazol-2-yl)amino)substituted acid
(6a-l) (Scheme 3, Table 2) from the compound (4) and different
types of amino acids (5a-l). The displacement of a methylthio
group by various amino acids from the C2 position of the
thiazolone ring and structures of the desired compounds (6a-l)
were confirmed by IR, 1H NMR and mass spectral analysis.
The IR spectrum of the representative compound (Z)-2-((4-o
xo-5-(thiophen-2-ylmethylene)-4,5-dihydrothiazol-2-yl)amin
o) propanoic acid (6a), showed a strong absorption band atScheme 3 Synthesis of (Z)-2-((4-oxo-5-(thiophen-2-ylmethyle
Please cite this article in press as: D.N. Pansare, D.B. Shinde, A facile synthesis o
amino) substituted acid, Journal of Saudi Chemical Society (2015), http://dx.doi.or1734 cm1 that is due to a carbonyl of carboxylic group and
3397 cm1 due to hydroxyl of the carboxylic group. The mass
spectrum revealed a molecular ion peak at m/z= 282.34 cor-
responding to a molecular formula C13H11FN2O3S. Their
1H
NMR spectra revealed the signals of (6a) as a representative
example, show one signal for the methyne proton in the range
d 7.30 ppm, thiophene ring proton shows the multiplet in the
range d 7.50–7.90 ppm, one of the methyl group proton shows
a doublet in the range of d 1.20–1.30 ppm and adjacent to car-
boxylic acid proton shows a quartet in the range of d 4.50–
4.70 ppm, amine group proton shows a singlet in the range
of d 9.90 ppm, carboxylic acid proton shows a singlet in the
range of d 13.05 ppm.
The plausible reaction mechanism for the synthesis of (Z)-
2-((4-oxo-5-(thiophen-2-ylmethylene)-4,5-dihydrothiazol-2-yl)
amino)propanoic acid (Scheme 4). The initial reaction conden-
sation of thiophene-2-carbaldehyde and 2-thioxothiazolidin-4-
one (1) at reflux temperature (2) produced a conjugated
product with loss of water (3). After the addition of
triethylamine, it abstracts the proton from the nitrogen atomne)-4,5-dihydrothiazol-2-yl)amino) substituted acid (6a-l).
f novel series (Z)-2-((4-oxo-5-(thiophen-2-ylmethylene)-4,5-dihydrothiazol-2-yl)
g/10.1016/j.jscs.2015.10.005
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Scheme 4 Plausible reaction mechanism for the synthesis of (Z)-2-((4-oxo-5-(thiophen-2-ylmethylene)-4,5-dihydrothiazol-2-yl)amino)
propanoic acid.
6 D.N. Pansare, D.B. Shinde(4), resonance occurs and a negative charge is acquired by
sulfur (5) which was displaced to iodine from iodomethane
to produce compound (6). After the addition of l-alanine it
was displaced to the thiomethyl group by the amine group of
l-alanine to produce the final product (7).
3.1. Highlight of the synthesis of novel (Z)-2-((4-oxo-5-
(thiophen-2-ylmethylene)-4,5-dihydrothiazol-2-yl)amino)
substituted acid (6a-l)
The novelty and highlight in the synthesis of (Z)-2-((4-oxo-5-
(thiophen-2-ylmethylene)-4,5-dihydrothiazol-2-yl)amino)sub
stituted acids are (i) It is the first reported synthesis, using etha-
nol as solvent, (ii) Development of an eco-friendly process by
the omission of organic solvents, (iii) Evasion of cumbersome
workup procedures (iv) Ethanol is non-toxic and economically
feasible to use in this reaction and also gives (v) Excellent
yields in a shorter reaction time making the process economi-
cally lucrative for industrial applications.
4. Conclusion
In conclusion, the objective of the our present study is to syn-
thesize some novel (Z)-2-((4-oxo-5-(thiophen-2-ylmethylene)-
4,5-dihydrothiazol-2-yl)amino)substituted acid with the hope
of discovering new structures that could be used as potent
antimicrobial agents and less cytotoxic compounds. Our aim
has been verified by the synthesis of the thiazolone moiety
and attachment to the C2 position of different types of amino
acids. The reactionis reported at room temperature with less
reaction time and good to excellent yields.Please cite this article in press as: D.N. Pansare, D.B. Shinde, A facile synthesis o
amino) substituted acid, Journal of Saudi Chemical Society (2015), http://dx.doi.orAcknowledgments
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